Filtros de búsqueda

Lista de obras de

Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study

artículo científico publicado en 2016

Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma

artículo científico publicado en 2014

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

artículo científico publicado en 2014

PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma

artículo científico publicado en 2014

Postibrutinib outcomes in patients with mantle cell lymphoma

artículo científico publicado en 2016

Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

artículo científico publicado en 2016

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era

scientific article published on 07 January 2019

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda